INTERFERON-BETA-1B TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS DECREASES CD3-MEDIATED TUMOR-NECROSIS-FACTOR-ALPHA AND INCREASES CD3-MEDIATED INTERLEUKIN-6 PRODUCTION EX-VIVO
Gd. Marshall et al., INTERFERON-BETA-1B TREATMENT OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS DECREASES CD3-MEDIATED TUMOR-NECROSIS-FACTOR-ALPHA AND INCREASES CD3-MEDIATED INTERLEUKIN-6 PRODUCTION EX-VIVO, Neurology, 46(2), 1996, pp. 1075-1075